San Francisco, California, March 16, 2018 : The global market for 3D printed drugs is primarily driven by the nascent technologies that have cropped up in the domain of 3D printing. In the past, 3D printing incurred exorbitantly high expenses which constrained its popularity. However, the current scenario has seen new 3D printing technologies that are cost-effective, thus, making it a viable option for a number of industries. This has also boosted demand for 3D printing drugs that are highly soluble and can be easily swallowed. TMR Research presents a report elaborating the fettle of the market for 3D printing drugs. The report titled ‘3D Printed Drug Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025’ is a succinct portrayal of a number of forces prevalent in the market.
Get Sample Copy of this Report @
The medical fraternity is on the lookout for customizing drugs for patients, and 3D printed drugs can play a key role in helping accomplish this goal. Hence, the demand within the global market is expected to reach unprecedented levels over the course of the next few years. Moreover, the market is also expected to surge ahead on account of the need to have colorful, well-designed, and well-tasting tablets. However, the lack of regulations with regards to 3D printed drugs is acting as a major constraint, which needs to be dealt with by government bodies.
The markets in North America and Europe have emerged as the key regional segments in recent times. The increasing investments in research and development across these regions have played a pivotal role in enlacing market growth.
Aprecia Pharmaceuticals holds a monopoly across the global market for 3D printed drug market